| |
| |
|
| Insider
Information: |
Meyers Peter A. |
| Relationship: |
Chief Financial Officer |
| City: |
Malvern |
| State: |
PA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
43,615 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$207,171 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
43,615 |
|
|
| Total
Value |
$207,171 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Eagle Pharmaceuticals, Inc. |
EGRX |
Chief Financial Officer |
2020-01-23 |
43,615 |
2017-06-12 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
8 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| EGRX |
Eagle Pharmaceuticals, In... |
Chief Financial Officer |
• – – |
2020-01-23 |
4 |
D |
$57.98 |
$95,841 |
D/D |
(1,653) |
43,615 |
0 |
- |
|
| EGRX |
Eagle Pharmaceuticals, In... |
Chief Financial Officer |
• – – |
2020-01-07 |
4 |
D |
$57.38 |
$36,264 |
D/D |
(632) |
45,268 |
0 |
- |
|
| EGRX |
Eagle Pharmaceuticals, In... |
Chief Financial Officer |
• – – |
2020-01-05 |
4 |
A |
$0.00 |
$0 |
D/D |
19,500 |
45,900 |
0 |
- |
|
| EGRX |
Eagle Pharmaceuticals, In... |
Chief Financial Officer |
• – – |
2019-01-23 |
4 |
A |
$0.00 |
$0 |
D/D |
19,300 |
26,400 |
0 |
- |
|
| EGRX |
Eagle Pharmaceuticals, In... |
Chief Financial Officer |
• – – |
2019-01-07 |
4 |
D |
$41.33 |
$24,798 |
D/D |
(600) |
7,100 |
0 |
- |
|
| EGRX |
Eagle Pharmaceuticals, In... |
Chief Financial Officer |
• – – |
2018-01-07 |
4 |
A |
$0.00 |
$0 |
D/D |
7,000 |
7,700 |
0 |
- |
|
| EGRX |
Eagle Pharmaceuticals, In... |
Chief Financial Officer |
• – – |
2017-08-16 |
4 |
B |
$55.45 |
$19,406 |
D/D |
350 |
700 |
2.74 |
- |
|
| EGRX |
Eagle Pharmaceuticals, In... |
Chief Financial Officer |
• – – |
2017-06-12 |
4 |
B |
$71.49 |
$25,021 |
D/D |
350 |
350 |
2.74 |
- |
|
8 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
